Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 5
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
Baysson H, Pennachio F, Wisniak A, Zabella ME, Pullen N, Collombet P, Lorthe E, Joost S, Balavoine JF, Bachmann D, Azman A, Pittet D, Chappuis F, Kherad O, Kaiser L, Guessous I, Stringhini S; Specchio-COVID19 study group. Baysson H, et al. BMJ Open. 2022 Jan 31;12(1):e055515. doi: 10.1136/bmjopen-2021-055515. BMJ Open. 2022. PMID: 35105645 Free PMC article.
Prevalence and predictors of psychological distress before, during, and after a COVID-19 pandemic wave in Switzerland, 2021.
Schrempft S, Pullen N, Baysson H, Wisniak A, Zaballa ME, Pennacchio F, Vollenweider P, Marques-Vidal P, Preisig M, Guessous I, Stringhini S; Specchio-COVID19 study group. Schrempft S, et al. J Psychiatr Res. 2023 Feb;158:192-201. doi: 10.1016/j.jpsychires.2022.12.042. Epub 2022 Dec 27. J Psychiatr Res. 2023. PMID: 36592533 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak.
Stringhini S, Zaballa ME, Perez-Saez J, Pullen N, de Mestral C, Picazio A, Pennacchio F, Wisniak A, Richard A, Baysson H, Loizeau A, Balavoine JF, Trono D, Pittet D, Posfay-Barbe K, Flahault A, Chappuis F, Kherad O, Vuilleumier N, Kaiser L, Azman AS, Guessous I; Specchio-COVID19 Study Group. Stringhini S, et al. Lancet Infect Dis. 2021 May;21(5):600-601. doi: 10.1016/S1473-3099(21)00054-2. Epub 2021 Feb 1. Lancet Infect Dis. 2021. PMID: 33539733 Free PMC article. No abstract available.
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study.
Dumont R, Nehme M, Lorthe E, De Mestral C, Richard V, Baysson H, Pennacchio F, Lamour J, Semaani C, Zaballa ME, Pullen N, Perrin A, L'Huillier AG, Posfay-Barbe KM, Guessous I, Stringhini S; Specchio-COVID19 study group. Dumont R, et al. BMJ Open. 2022 Nov 21;12(11):e063504. doi: 10.1136/bmjopen-2022-063504. BMJ Open. 2022. PMID: 36410813 Free PMC article.
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance.
Perez-Saez J, Zaballa ME, Yerly S, Andrey DO, Meyer B, Eckerle I, Balavoine JF, Chappuis F, Pittet D, Trono D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS; Specchio-COVID19 Study Group. Perez-Saez J, et al. Clin Microbiol Infect. 2021 Nov;27(11):1695.e7-1695.e12. doi: 10.1016/j.cmi.2021.06.040. Epub 2021 Jul 7. Clin Microbiol Infect. 2021. PMID: 34245905 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
Stringhini S, Zaballa ME, Pullen N, Perez-Saez J, de Mestral C, Loizeau AJ, Lamour J, Pennacchio F, Wisniak A, Dumont R, Baysson H, Richard V, Lorthe E, Semaani C, Balavoine JF, Pittet D, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe K, Kaiser L, Guessous I; Specchio-COVID19 study group. Stringhini S, et al. Euro Surveill. 2021 Oct;26(43):2100830. doi: 10.2807/1560-7917.ES.2021.26.43.2100830. Euro Surveill. 2021. PMID: 34713799 Free PMC article.
13 results